Search

Author/Creator Cavelti-Weder, Claudia

1. Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial. (November 2022)

Authors:
Hepprich, Matthias; Mudry, Jonathan M.; Gregoriano, Claudia; Jornayvaz, Francois R.; Carballo, Sebastian; Wojtusciszyn, Anne; Bart, Pierre-Alexandre; Chiche, Jean-Daniel; Fischli, Stefan; Baumgartner, Thomas; Cavelti-Weder, Claudia; Braun, Dominique L.; Günthard, Huldrych F.; Beuschlein, Felix; C...
Journal:
EClinicalMedicine
Issue:
Volume 53(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver. Issue 1 (December 2018)

Authors:
AlAsfoor, Shefaa; Rohm, Theresa; Bosch, Angela; Dervos, Thomas; Calabrese, Diego; Matter, Matthias; Weber, Achim; Cavelti-Weder, Claudia
Journal:
Scientific reports
Issue:
Volume 8:Issue 1(2018)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search